Found: 7
Select item for more details and to access through your institution.
Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 2, p. 222, doi. 10.3390/ph16020222
- By:
- Publication type:
- Article
The Waxing, Waning, and Predictors of Humoral Responses to Vector-Based SARS-CoV-2 Vaccine in Hemodialysis Patients.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1537, doi. 10.3390/vaccines10091537
- By:
- Publication type:
- Article
Comparison of Adverse Kidney Outcomes With Empagliflozin and Linagliptin Use in Patients With Type 2 Diabetic Patients in a Real-World Setting.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.781379
- By:
- Publication type:
- Article
Ultrasonography Measurement of Renal Dimension and Its Correlation with Age, Body Indices, and eGFR in Type 1 Diabetes Mellitus Patients: Real World Data in Taiwan.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 3, p. 1109, doi. 10.3390/jcm12031109
- By:
- Publication type:
- Article
Red mercurochrome-associated acute kidney injury successfully treated by chelation therapy.
- Published in:
- Nephrology, 2013, v. 18, n. 12, p. 843, doi. 10.1111/nep.12135
- By:
- Publication type:
- Article
Real-World Effectiveness of SARS-CoV-2 Vaccine Booster in Hemodialysis Patients with COVID-19 Receiving Molnupiravir.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 2, p. 543, doi. 10.3390/v15020543
- By:
- Publication type:
- Article
Comparative Adverse Kidney Outcomes in Women Receiving Raloxifene and Denosumab in a Real-World Setting.
- Published in:
- Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071494
- By:
- Publication type:
- Article